Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets ...

Universal CAR T cells produce rapid remissions and enable allogeneic stem cell transplants in patients with relapsed or refractory T-cell acute lymphoblastic leukemia.

As people age, their immune system function declines. T cell populations become smaller and can't react to pathogens as ...

CellVoyant, a U.K.-based startup, has launched an AI platform that allows scientists to predict the future health and ...

Researchers at the Johns Hopkins Kimmel Cancer Center’s Ludwig Center developed a new treatment that selectively targets ...

Scientists at St. Jude Children's Research Hospital have characterized a hidden intermediate state at the center of Src ...

Researchers at the Max Delbrück Center have found that a cellular housekeeping mechanism called autophagy plays a major role ...

Kyverna Therapeutics is upgraded to Buy based on strengthened financials and the potential for commercial launch by the end ...

Such an advancement would allow for one of the most successful non-chemo cancer treatments to be done both faster and cheaper ...

The cellular therapy landscape continues to evolve beyond hematologic malignancies, now making significant progress in solid ...

In a person living with HIV, proviruses—strands of HIV DNA—are typically integrated into the T cell genome and become a ...